Marchés français ouverture 4 h 5 min

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
150,40+4,70 (+3,23 %)
À la clôture : 4:03PM EDT
149,44 -0,96 (-0,64 %)
Échanges après Bourse : 04:59PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 267 6131
http://www.zimmerbiomet.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein20 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Bryan C. HansonChairman, Pres & CEO3,03MS.O.1967
Mr. Suketu P. UpadhyayExec. VP & CFO1,34MS.O.1969
Mr. Ivan TornosGroup Pres of Global Bus.es, The Americas & EMEA Region and COO1,49MS.O.1976
Mr. Sang YiGroup Pres of Asia Pacific1,22MS.O.1962
Ms. Carrie A. Nichol CPAVP, Controller & Chief Accounting OfficerS.O.S.O.1980
Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerS.O.S.O.S.O.
Mr. Zeeshan TariqSr. VP & Chief Information OfficerS.O.S.O.S.O.
Ms. Keri P. MattoxSr. VP of Investor Relations & Chief Communications OfficerS.O.S.O.S.O.
Mr. Chad F. PhippsSr. VP, Gen. Counsel & Sec.S.O.S.O.1972
Ms. Angela MainSr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia PacificS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2020 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Zimmer Biomet Holdings, Inc. en date du 1 juillet 2021 est 3. Les scores principaux sont Audit : 8; Société : 5; Droits des actionnaires : 3; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.